SearchDictionaryMobileLogin

Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection.

AbstractThe characterization of the cross-reactive, or heterologous, neutralizing antibody responses developed during human immunodeficiency virus type 1 (HIV-1) infection and the identification of factors associated with their generation are relevant to the development of an HIV vaccine. We report that in healthy HIV-positive, antiretroviral-naïve subjects, the breadth of plasma heterologous neutralizing antibody responses correlates with the time since infection, plasma viremia levels, and the binding avidity of anti-Env antibodies. Anti-CD4-binding site antibodies are responsible for the exceptionally broad cross-neutralizing antibody responses recorded only in rare plasma samples. However, in most cases examined, antibodies to the variable regions and to the CD4-binding site of Env modestly contributed in defining the overall breadth of these responses. Plasmas with broad cross-neutralizing antibody responses were identified that targeted the gp120 subunit, but their precise epitopes mapped outside the variable regions and the CD4-binding site. Finally, although several plasmas were identified with cross-neutralizing antibody responses that were not directed against gp120, only one plasma with a moderate breadth of heterologous neutralizing antibody responses contained cross-reactive neutralizing antibodies against the 4E10 epitope, which is within the gp41 transmembrane subunit. Overall, our study indicates that more than one pathway leads to the development of broad cross-reactive neutralizing antibodies during HIV infection and that the virus continuously escapes their action.
AuthorsD Noah Sather, Jakob Armann, Lance K Ching, Angeliki Mavrantoni, George Sellhorn, Zachary Caldwell, Xuesong Yu, Blake Wood, Steve Self, Spyros Kalams, Leonidas Stamatatos (Affiliation: Seattle Biomedical Research Institute, Seattle, Washington 98109, USA.)
JournalJournal of virology (J Virol) Vol. 83 Issue 2 Pg. 757-69 (Jan 2009) ISSN: 1098-5514 United States
PMID18987148 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Epitopes
  • HIV Antibodies
  • env Gene Products, Human Immunodeficiency Virus
Topics
  • Cross Reactions
  • Epitope Mapping
  • Epitopes (immunology)
  • Female
  • HIV Antibodies (blood)
  • HIV Infections (immunology)
  • HIV-1 (immunology)
  • Humans
  • Male
  • Neutralization Tests
  • env Gene Products, Human Immunodeficiency Virus (immunology)